Cidara Therapeutics - REZZAYO - Ownership and Business Overview

Life ScienceCompany

Cidara Therapeutics - REZZAYO Ownership

Who owns Cidara Therapeutics - REZZAYO?

Cidara Therapeutics - REZZAYO is owned by Mundipharma International. It was acquired on April 24, 2024.

Cidara Therapeutics - REZZAYO Business Overview

Where is Cidara Therapeutics - REZZAYO headquartered?

Cidara Therapeutics - REZZAYO is headquartered in San Diego, California.

What sector is Cidara Therapeutics - REZZAYO in?

Cidara Therapeutics - REZZAYO is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 96 acquisitions of life science companies in 2024, including 7 acquisitions by private equity firms, and 89 by strategics.

Cidara Therapeutics - REZZAYO

Cidara Therapeutics - REZZAYO

San Diego, California 92121
United States,

Cidara Therapeutics' REZZAYO is a novel once weekly echinocandin indicated for the treatment of invasive candidiasis in adults. Cidara Therapeutics' REZZAYO is based in San Diego, California.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.